Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

H.I.G.’s Capstone Puts Customers First With Custom Formulations

This article was originally published in The Tan Sheet

Executive Summary

The private equity firm’s H.I.G. Growth Partners capital investment affiliate merges two of its businesses, Integrity Nutraceuticals and Cornerstone Research & Development, into Capstone Nutrition. CEO Greg Horn says “we really occupy a niche” in “a pretty fragmented industry” with custom formulations for every product.

You may also be interested in...



Wellness Business Roundup: VSI Gets Personal, GNC Gets Brazil Partner, Brightstar Adds Capstone, US Firm Has German CBD Partner

Vitamin Shoppe launches Only Me personalized program/subscription service; GNC expands into “key” target market with Brazilian retail operator; Brightstar to acquire Capstone from H.I.G.; Columbia Care partners with Germany's Moeller on CBD-infused products.

Viehbacher On Before Brands Board: Health And Wellness Industry News Roundup

Viehbacher’s investment group backs start-up supplement firm; Former Starbucks executive joins Jamba Juice as COO; and MusclePharm forecasts turning corner in 2017.

Executive Decisions Roundup: MusclePharm, Galderma, Vitamin Shoppe

MusclePham appoints operations VP; Essential Oils taps COO; ASEA signs athlete representatives; and more news in brief.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel